SecBot SecBot
6-K ·Filed Oct 6, 2026

EVGN

Evogene Ltd.
BULLISH
Impact 6/10
Horizonweeks Processed21d 6h ago SEC0001178913-26-004722
Notable filing: 6-K
Actionable Insight ▲ Bullish

The cooperation agreement de-escalates a contentious activist campaign and replaces a threatened tender offer with board representation. Monitor the November 10 special meeting vote — approval is likely given the board's unanimous recommendation and the activists' ~17% stake. The 60-day standstill on share issuance removes near-term ATM dilution risk. Watch for strategic direction changes under the new board majority.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
EVGN ▼ -7.57% at T+5d
LONG call ✗ call lost -7.57% · α vs SPY -6.59% · entry $0.4106 → $0.3795
Next anchor: T+20d in 6d
Latest observation: T+12 -14.04% FF3 residual α
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
-2.95%
call -2.95% · α -2.52%
$0.3985
settled 21d ago
T+5d
-7.57%
call -7.57% · α -6.59%
$0.3795
settled 15d ago
T+20d
Pending
in 6d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Evogene entered into a cooperation agreement with activist shareholders L.I.A. Pure Capital and Invest-Pro, resolving a proxy contest and a threatened special tender offer. The agreement reconstitutes the board with four Pure Capital nominees and three continuing directors, includes mutual releases and a 60-day standstill, and requires shareholder approval at a November 10, 2026 special meeting.

Key Facts

  • Cooperation agreement dated October 6, 2026 between Evogene and L.I.A. Pure Capital Ltd. and Invest Pro Shukai Hon Ltd.
  • Pure Capital Group beneficially owns 3,057,488 ordinary shares, representing approximately 16.93% of outstanding shares.
  • Activist shareholders had threatened a special tender offer at not less than $0.55 per share and challenged the September 4, 2026 AGM results.
  • Board reconstituted: 4 Pure Capital nominees (Oz Adler, Dr. Adi Zuloff-Shani, Itay Maroz, Shahar Zadok) and 3 continuing directors (Ofer Haviv, Nir Nimrodi, Leon Y. Recanati).
  • Continuing directors to serve a transition period of up to six months.
  • 60-day standstill: Pure Capital withdraws tender offer notice; Evogene agrees not to issue shares or convertible securities (except employee grants).
  • Special general meeting scheduled for November 10, 2026 to vote on director elections and the cooperation agreement.
  • Mutual waivers and releases of all claims related to the AGM, demand letters, and the tender offer.

Financial Impact

Resolution of activist dispute removes overhang of a hostile tender offer at $0.55/share and costly litigation. The 60-day share issuance standstill caps near-term dilution risk.

dilutiongovernance

Risk Factors

  • Shareholder approval of the cooperation agreement is required; failure would terminate the agreement and could reignite the activist conflict.
  • The 60-day standstill on share issuance is temporary; dilution risk resumes after that period.
  • The transition period for continuing directors is only up to six months, creating potential for further board instability.
  • No financial terms or operational commitments were disclosed — the agreement is purely governance-focused.

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001178913-26-004722
Exhibit: exhibit_99-1.htm0001178913-26-004722
Exhibit: exhibit_99-3.htm0001178913-26-004722
Exhibit: exhibit_99-4.htm0001178913-26-004722
Document: zk2636203.htm0001178913-26-004722
Document: 0001178913-26-004722-index-headers.html0001178913-26-004722
Document: 0001178913-26-004722-index.html0001178913-26-004722
Document: 0001178913-26-004722.txt0001178913-26-004722
16 reports for EVGN
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 4 of 7 best @ T+20▲ +27.07%May 20, 2026
Filters
Rows
Reports for EVGN — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
3
NEUTRAL ★ 2/10
$0.3641awaiting T+60—$0.3600 (−1.13%)
Oct 6, 2026
21d ago
SC 13D/A
BULLISH ★ 6/10
$0.4106awaiting T+60—$0.3600 (−12.32%)
Oct 6, 2026
21d ago
6-K
BULLISH ★ 6/10
$0.4106awaiting T+60—$0.3600 (−12.32%)
Sep 30, 2026
27d ago
6-K
BEARISH ★ 6/10
$0.4000awaiting T+60—$0.3600 (+10.00%)
Sep 30, 2026
27d ago
EFFECT
BEARISH ★ 5/10
$0.4000awaiting T+60—$0.3600 (+10.00%)
Sep 4, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$0.5379awaiting T+60—$0.3600 (−33.07%)
Aug 18, 2026
10w ago
6-K
MIXED ★ 6/10
$0.5826awaiting T+60—$0.3600 (−38.21%)
Aug 14, 2026
10w ago
Press Release
NEUTRAL ★ 1/10
$0.6008awaiting T+60—$0.3600 (−40.08%)
Jul 31, 2026
12w ago
6-K
MIXED ★ 6/10
$0.5400 $0.3466▼ −35.81%▼ −37.60%$0.3600 (−33.33%)
Jun 16, 2026
19w ago
6-K
NEUTRAL ★ 3/10
$0.5600 $0.4806▼ −14.18%▼ −15.18%$0.3600 (−35.71%)
Showing 10 of 16

US Market Status

Market Closed — Opens Thu (11h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026